References
Frühwald MC, Biegel JA, Bourdeaut F et al (2016) Atypical teratoid/rhabdoid tumors-current concepts, advances in biology, and potential future therapies. Neuro Oncol 18:764–778
Hasselblatt M, Isken S, Linge A et al (2013) High-resolution genomic analysis suggests the absence of recurrent genomic alterations other than SMARCB1 aberrations in atypical teratoid/rhabdoid tumors. Genes Chromosom Cancer 52:185–190
Hasselblatt M, Johann P, Ho B et al (2018) Molecular subgroups of atypical teratoid/rhabdoid tumor (ATRT): towards a consensus. Neuro Oncol 20(Suppl 2):28–29
Johann PD, Erkek S, Zapatka M et al (2016) Atypical teratoid/rhabdoid tumors are comprised of three epigenetic subgroups with distinct enhancer landscapes. Cancer Cell 29:379–393
Torchia J, Golbourn B, Feng S et al (2016) Integrated (epi)-genomic analyses identify subgroup-specific therapeutic targets in CNS rhabdoid tumors. Cancer Cell 30:891–908
Nowak J, Nemes K, Hohm A et al (2018) Magnetic resonance imaging surrogates of molecular subgroups in atypical teratoid/rhabdoid tumor. Neuro Oncol 20:1672–1679
Johann PD, Hovestadt V, Thomas C et al (2017) Cribriform neuroepithelial tumor: molecular characterization of a SMARCB1-deficient non-rhabdoid tumor with favorable long-term outcome. Brain Pathol 27:411–418
Capper D, Jones DTW, Sill M et al (2018) DNA methylation-based classification of central nervous system tumours. Nature 555:469–474
Pajtler KW, Witt H, Sill M et al (2015) Molecular classification of ependymal tumors across All CNS compartments, histopathological grades, and age groups. Cancer Cell 27:728–743
Japp AS, Klein-Hitpass L, Denkhaus D et al (2017) OTX2 defines a subgroup of atypical teratoid rhabdoid tumors with close relationship to choroid plexus tumors. J Neuropathol Exp Neurol 76:32–38
Kordes U, Gesk S, Fruhwald MC et al (2010) Clinical and molecular features in patients with atypical teratoid rhabdoid tumor or malignant rhabdoid tumor. Genes Chromosom Cancer 49:176–181
Pinto EM, Hamideh D, Bahrami A et al (2018) Malignant rhabdoid tumors originating within and outside the central nervous system are clinically and molecularly heterogeneous. Acta Neuropathol 136:315–326
Funding
MH is supported by DFG (HA 3060/8-1).
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Thomas, C., Knerlich-Lukoschus, F., Reinhard, H. et al. Two molecularly distinct atypical teratoid/rhabdoid tumors (or tumor components) occurring in an infant with rhabdoid tumor predisposition syndrome 1. Acta Neuropathol 137, 847–850 (2019). https://doi.org/10.1007/s00401-019-02001-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00401-019-02001-3